Skip to main content

Th17 Cells in Transplantation: Actors or Innocent Bystanders?

  • Chapter
  • First Online:
IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity

Part of the book series: Progress in Inflammation Research ((PIR))

  • 1557 Accesses

Abstract

The recent interest for Th17 cells immediately raised questions about their possible involvement in allogeneic processes. Indeed, IL-17-producing innate immune cells and Th17 cells have now been related to allograft rejection and ischemia-reperfusion injury in clinical settings and in experimental models. Some of them clearly established a link between the presence of these cells and the development of long-term graft dysfunction. A pivotal role of a Th17-mediated pathway in transplant damage has been demonstrated independently of MHC disparities with T cells recognizing either autoantigen or minor transplantation antigen. The ambiguous relationship between regulatory T cells (Treg) and Th17 cells also complicates Treg-based therapy. Herein, we briefly discuss recent studies reporting Th17 and IL-17 involvements in allograft rejection processes.

L-MC, BV, and PL are first coauthors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Loong CC, Hsieh HG, Lui WY, Chen A, Lin CY (2002) Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 197:322ā€“332

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  2. Van Kooten C, Boonstra JG, Paape ME, Fossiez F, Banchereau J, Lebecque S, Bruijn JA, De Fijter JW, Van Es LA, Daha MR (1998) Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 9:1526ā€“1534

    PubMedĀ  Google ScholarĀ 

  3. Yapici U, Kers J, Bemelman FJ, Roelofs JJ, Groothoff JW, van der Loos CM, van Donselaar-van der Pant KA, Idu MM, Claessen N, Ten Berge IJ et al (2011) Interleukin-17 positive cells accumulate in renal allografts during acute rejection and are independent predictors of worse graft outcome. Transpl Int 24:1008ā€“1017

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  4. Benghiat FS, Charbonnier LM, Vokaer B, De Wilde V, Le Moine A (2009) Interleukin 17-producing T helper cells in alloimmunity. Transplant Rev (Orlando) 23:11ā€“18

    ArticleĀ  Google ScholarĀ 

  5. Vanaudenaerde BM, De Vleeschauwer SI, Vos R, Meyts I, Bullens DM, Reynders V, Wuyts WA, Van Raemdonck DE, Dupont LJ, Verleden GM (2008) The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 8:1911ā€“1920

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  6. Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, Strieter RM, Rosin DL, Okusa MD (2010) IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 120:331ā€“342

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  7. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, Iwaki T, Okada Y, Iida M, Cua DJ et al (2009) Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 15:946ā€“950

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  8. Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208:1367ā€“1376

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  9. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR et al (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 146:772ā€“784

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  10. Nakagiri T, Inoue M, Morii E, Minami M, Sawabata N, Utsumi T, Kadota Y, Ideguchi K, Tokunaga T, Okumura M (2010) Local IL-17 production and a decrease in peripheral blood regulatory T cells in an animal model of bronchiolitis obliterans. Transplantation 89:1312ā€“1319

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  11. Hata T, Takahashi M, Hida S, Kawaguchi M, Kashima Y, Usui F, Morimoto H, Nishiyama A, Izawa A, Koyama J et al (2011) Critical role of Th17 cells in inflammation and neovascularization after ischaemia. Cardiovasc Res 90:364ā€“372

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  12. Antonysamy MA, Fanslow WC, Fu F, Li W, Qian S, Troutt AB, Thomson AW (1999) Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 162:577ā€“584

    PubMedĀ  CASĀ  Google ScholarĀ 

  13. Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, Meyer KC, Hayney MS, Braun RK, Greenspan DS et al (2007) IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 117:3498ā€“3506

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  14. Braun RK, Molitor-Dart M, Wigfield C, Xiang Z, Fain SB, Jankowska-Gan E, Seroogy CM, Burlingham WJ, Wilkes DS, Brand DD et al (2009) Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection. Transplantation 88:1341ā€“1348

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  15. Vokaer B, Van Rompaey N, Lemaitre PH, Lhomme F, Kubjak C, Benghiat FS, Iwakura Y, Petein M, Field KA, Goldman M et al (2010) Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. J Immunol 185:3417ā€“3425

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  16. Chen L, Ahmed E, Wang T, Wang Y, Ochando J, Chong AS, Alegre ML (2009) TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol 182:6217ā€“6225

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  17. Burrell BE, Csencsits K, Lu G, Grabauskiene S, Bishop DK (2008) CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 181:3906ā€“3914

    PubMedĀ  CASĀ  Google ScholarĀ 

  18. Tesar BM, Du W, Shirali AC, Walker WE, Shen H, Goldstein DR (2009) Aging augments IL-17T-cell alloimmune responses. Am J Transplant 9:54ā€“63

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  19. Abadja F, Atemkeng S, Alamartine E, Berthoux F, Mariat C (2011) Impact of mycophenolic acid and tacrolimus on Th17-related immune response. Transplantation 92:396ā€“403

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  20. Li Y, Shi Y, Huang Z, Bai Y, Niu Q, Cai B, Wang L, Feng W (2011) CNI induced Th17/Treg imbalance and susceptibility to renal dysfunction in renal transplantation. Int Immunopharmacol 11(12):2033ā€“2038

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  21. Deteix C, Attuil-Audenis V, Duthey A, Patey N, McGregor B, Dubois V, Caligiuri G, Graff-Dubois S, Morelon E, Thaunat O (2010) Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 184:5344ā€“5351

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  22. Diaz JA, Booth AJ, Lu G, Wood SC, Pinsky DJ, Bishop DK (2009) Critical role for IL-6 in hypertrophy and fibrosis in chronic cardiac allograft rejection. Am J Transplant 9:1773ā€“1783

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  23. Loverre A, Tataranni T, Castellano G, Divella C, Battaglia M, Ditonno P, Corcelli M, Mangino M, Gesualdo L, Schena FP et al (2011) IL-17 expression by tubular epithelial cells in renal transplant recipients with acute antibody-mediated rejection. Am J Transplant 11:1248ā€“1259

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  24. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, Dā€™Addio F, Mfarrej B, Donnarumma M, Habicht A, Clarkson MR, Iacomini J, Glimcher LH et al (2008) A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 205:3133ā€“3144

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  25. Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I, LeBon T, Kandeel F, Forman S, Zeng D (2008) Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 112:2101ā€“2110

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  26. Benghiat FS, Craciun L, De Wilde V, Dernies T, Kubjak C, Lhomme F, Goldman M, Le Moine A (2008) IL-17 production elicited by allo-major histocompatibility complex class II recognition depends on CD25posCD4pos T cells. Transplantation 85:943ā€“949

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  27. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179ā€“189

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  28. Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, Hernandez-Santos N, Edgerton M, Gaffen SL, Lenardo MJ (2011) CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34:422ā€“434

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  29. Chen Y, Haines CJ, Gutcher I, Hochweller K, Blumenschein WM, McClanahan T, Hammerling G, Li MO, Cua DJ, McGeachy MJ (2011) Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34:409ā€“421

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  30. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ (2007) TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8:1390ā€“1397

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

  31. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S, Lee J, de Sauvage FJ, Ghilardi N (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7:929ā€“936

    ArticleĀ  PubMedĀ  CASĀ  Google ScholarĀ 

Download references

Acknowledgments

Ph. LM is supported by a grant from the Fonds National de la Recherche Scientifique (FNRS/FRSM) and B.V. by a grant from the SociƩtƩ Francophone de Transplantation (SFT). ALM is a researcher associate from the FNRS. A part of this work was supported by a ROTRF grant (Roche Organ Transplantation Research Foundation)

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alain Le Moine .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

Ā© 2013 Springer Basel

About this chapter

Cite this chapter

Charbonnier, LM., Vokaer, B., LemaƮtre, P., Moine, A.L. (2013). Th17 Cells in Transplantation: Actors or Innocent Bystanders?. In: Quesniaux, V., Ryffel, B., Padova, F. (eds) IL-17, IL-22 and Their Producing Cells: Role in Inflammation and Autoimmunity. Progress in Inflammation Research. Springer, Basel. https://doi.org/10.1007/978-3-0348-0522-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-0522-3_13

  • Published:

  • Publisher Name: Springer, Basel

  • Print ISBN: 978-3-0348-0521-6

  • Online ISBN: 978-3-0348-0522-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics